Home / Health / Indian Rabies Vaccine Linked to Counterfeit Scare
Indian Rabies Vaccine Linked to Counterfeit Scare
27 Dec
Summary
- Australian authorities issued an advisory on counterfeit rabies vaccines.
- Indian Immunologicals Ltd confirmed an isolated counterfeit incident in January.
- IIL is a subsidiary of NDDB and makes vaccines affordable.
Australian health authorities have issued an advisory concerning counterfeit rabies vaccines being distributed in India. Indian Immunologicals Ltd (IIL), the manufacturer of the Abhayrab vaccine, has acknowledged an isolated incident involving a single batch that occurred in January.
The company proactively reported the issue to Indian regulators and has since increased its surveillance measures. IIL has communicated with the Australian health authorities, providing details of the incident and requesting a revision of their advisory. They emphasize that healthcare professionals should procure the vaccine through authorized channels to ensure authenticity.
IIL, a subsidiary of the National Dairy Development Board, was established to ensure the affordability of vaccines, including rabies vaccines, within India. The company has a significant global reach, exporting to over 40 countries and having sold approximately 210 million doses in the past 25 years.
